Fabio Ynoe de Moraes: The Power of Laser Focus - Lessons from Carlos Alcaraz

Fabio Ynoe de Moraes

Anu Agrawal: The 10th Global Health Catalyst Summit to Advance Global Cancer Collaboration

Anu Agrawal

ESGO President-Elect Jalid Sehouli's Message on World Gynecologic Oncology Day 2025

Jalid Sehouli

Vincent Rajkumar: Key Takeaways From IMS25

Vincent Rajkumar, IMS25

Top 10 Oncogrants of the Week: Fueling the Next Wave of Cancer Research and Innovation

Top 10 Oncogrants of the Week: Fueling the Next Wave of Cancer Research and Innovation

More Than $358 Million Invested in Hope, Progress and Cures - Rally Foundation for Childhood Cancer Research

Childhood Cancer

Douglas Flora: The Ultimate Two-Person Performance Review

Douglas Flora

Robin Zon: ASCO Launches ASCO Edge to Strengthen Practice Management and Patient Care

Robin Zon

Dinesh Pendharkar: Discussing Avenues for Collaboration with Yerbol Bekmukhambetov

Fabio Ynoe de Moraes
Voices

Fabio Ynoe de Moraes: The Power of Laser Focus - Lessons from Carlos Alcaraz

Anu Agrawal
Voices

Anu Agrawal: The 10th Global Health Catalyst Summit to Advance Global Cancer Collaboration

Jalid Sehouli
Voices

ESGO President-Elect Jalid Sehouli's Message on World Gynecologic Oncology Day 2025

SWOG Unveils LeAP-D Course and Welcomes 28th Cohort of Early Career Investigators

10 Must-Read Posts in Immuno-Oncology This Week

Sushil Beriwal: Practice-Changing Advances in Cervical Cancer Care

10 Oncologists Join OncoDaily Medical Journal’s Editorial Team

Advancing Sustainable Patient Navigation in Cancer Care with Jill Biden - American Cancer Society

The 7th CUHK Sarcoma Masterclass Happening Right Now (20 September, 2025)

Princess Ghida Talal: Grateful to Everyone Who Supported the Al-Hussein Cancer Center Sustainability Fund

awards
awards
awards
awards
awards
awards

Voices
Dinesh Pendharkar

Dinesh Pendharkar: Discussing Avenues for Collaboration with Yerbol Bekmukhambetov

Maite Gorostegui: Advancing Childhood Cancer Care Through City Cancer Challenge Partnership

Nelson Dusetti: Exploiting TGF-β-mediated Stromal Programming in Homologous

Congratulations to Simon Brennan on Receiving Fellow of ARMS Award - Flinders University

Martín Igor Gómez-Randulfe Joins EGFR+ Lung Cancer Conference in Manchester

Adam Dicker: Patient Perceptions of AI in Healthcare

Devika Das: Phenomenal Addition to Our Options for Cancer Treatment

Celebrities and Cancer

OncoCalendar

ESMO Guidelines 2025: Real World Cases - Webinar Series on Melanoma

European Society For Medical Oncology (ESMO)

24 Sep
ESMO Guidelines 2025

The ESMO Advanced Course on ADC Development, Therapeutic Applications, and Research in Thoracic Cancers 2025

European Society For Medical Oncology (ESMO)

24 Sep
esmo

The ESO Refresher Course on Breast Cancer

European School of Oncology

21 Nov
ESO

CCI4EU 3rd Capacity Building Conference on Effective Patient Pathways

European School of Oncology

15 Oct
CCI4EU Conference

10th ESO SIOPE Masterclass in Paediatric Oncology

European School of Oncology

01 Oct
ESO SIOPE

Immune-oncology
Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

10 Must-Read Posts in Immuno-Oncology This Week

LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC

Top Immunotherapy Trials in Head and Neck and Endocrine Cancers to Watch at ESMO 2025

10 Must-Read Posts in Immuno-Oncology This Week

BOT/BAL Advancements, BATTMAN Trial, FDA Approval Challenges and Key Highlights from Agenus Stakeholder Briefing

ROWAN Study of TheraSphere with Durvalumab and Tremelimumab in HCC Completed Enrollment

OncoGrants
Ruth L. Kirschstein NRSA Individual Predoctoral Fellowship

Ruth L. Kirschstein NRSA Individual Predoctoral Fellowship

Ruth L. Kirschstein NRSA Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Programs

Ruth L. Kirschstein NRSA Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Programs

Support for Research Excellence Award

Support for Research Excellence Award (R16 — Clinical Trial Not Allowed)

Support for Research Excellence – First Independent Research Award

Support for Research Excellence – First Independent Research Award (R16 — Clinical Trial Not Allowed)

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 — Basic Experimental Studies with Humans Required)

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 — Basic Experimental Studies with Humans Required)

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 — Clinical Trial Not Allowed)

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 — Clinical Trial Not Allowed)

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care
Oncologist Near Me

Oncologist Near Me - Guillermo Chantada: A Leading Expert in Pediatric Oncology

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologist
Aparna Parikh

Aparna Parikh

Boston, USA
Rachna Shroff

Rachna Shroff

Tucson, USA
Gregory Kalemkerian

Gregory Kalemkerian

Ann Arbor, USA
Hagop-Kantarjian

Hagop Kantarjian

Houston, USA
Sarkis Meterissian

Sarkis Meterissian

Montreal, Canada
Florian Lordick

Florian Lordick

Leipzig, Germany
LIdia Schapira

Lidia Schapira

Stanford, USA
Matti Aapro

Matti Aapro

Genolier, Switzerland
Rob Pieters

Rob Pieters

Utrecht, Netherlands
Giuseppe Curigliano

Giuseppe Curigliano

Milan, Italy
Yelena Janjigian

Yelena Janjigian

New York, USA

Oncology Drugs
Zongertinib (Hernexeos)

Zongertinib (Hernexeos) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More

Unreleased Decision Letters From 2024–2025 Now Available - FDA

Dordaviprone (Modeyso) 2025: What patients need to know?

The FDA Has Granted Accelerated Approval to Zongertinib - The Babak Lab

Dordaviprone (Modeyso) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and more

Zanidatamab (Ziihera): Patient Guide for 2025

Zanidatamab (Ziihera) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More

OncoDaily Magazine

awards
awards
awards
awards
awards
awards

New Paper Alert
Durvalumab after Radiotherapy in Patients with Unresectable Stage III Non Small Cell Lung Cancer Ineligible for Chemotherapy

Durvalumab after Radiotherapy in Patients with Unresectable Stage III Non Small Cell Lung Cancer Ineligible for Chemotherapy

CABATEN Trial

New Paper Alert: CABATEN Trial Results- Cabozantinib and Atezolizumab Show Durable Responses in Rare Endocrine Cancers

A Systematic Review and Meta-Analysis of Cancer in Inborn Errors of Immunity

A Systematic Review and Meta-Analysis of Cancer in Inborn Errors of Immunity

Nationwide Real-World Evidence of Immunotherapy in Armenia

Nationwide Real-World Evidence of Immunotherapy in Armenia

Amivantamab–Lazertinib Improves Survival Over Osimertinib in EGFR-Mutated NSCLC

Amivantamab–Lazertinib Improves Survival Over Osimertinib in EGFR-Mutated NSCLC

Treatment Abandonment

Childhood Cancer in Pakistan: Factors Driving Treatment Abandonment at a Tertiary Center

OncoDaily Medical Journal

Precision Oncology

10.69690/ODMJ-019-0829-4588

Harnessing Real-World Evidence to Support Precision Oncology
Opinion

Pediatric Oncology

10.69690/ODMJ-001-0829-4568

Identifying the Factors Contributing to Treatment Abandonment in Childhood Cancers at a Tertiary Care Hospital in Pakistan
Original Research

Global Oncology

10.69690/ODMJ-001-0811-4701

The Role of National and Regional Cancer Registries in Shaping Cancer Care Policies
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0809-4599

Survival Outcomes of Wilms' Tumor in Pediatric Patients Treated at KFMC: A Retrospective Study of 15 years from 2007-2022
Original Research

GI Oncology

10.69690/ODMJ-018-0425-4320

Colorectal Cancer in Latin America: Quick Comment
Commentaries

GI Oncology

10.69690/ODMJ-002-0701-4309

Current Perspective of Gastro-intestinal Cancer in Guatemala
Review/Meta-Analysis

Pediatric Oncology

10.69690/ODMJ-003-0520-4233

In the Crossfire: A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group
Editorial

Pediatric Oncology

10.69690/ODMJ-018-0425-4062

CD19+ CAR-T Therapy for Relapsed or Refractory B-ALL and Burkitt Lymphoma in Children and Young Adults in the Republic of Belarus
Abstracts